DirectorInsight Announces Corporate Rebrand
DirectorInsight, a leading provider of corporate governance analytics and solutions, is delighted to announce that the company will now operate under the new brand name CGLytics . Short for Corporate Governance Analytics, this rebrand elevates the focus on providing powerful, data-driven solutions to board members and institutional investors, allowing for better engagement, decision-making and stewardship.
CGLytics is an Environmental, Social & Governance (ESG) SaaS solution provider that specializes in the corporate governance space. The technology provides an integrated cloud-based, data-fueled solution, to independently analyze information on the value creation and governance practices of leading listed companies across the globe.
Over the past few years, the business has expanded and developed new capabilities across all spectrums of corporate governance analytics software, while continuing to embrace a customer-centric approach in its everyday operations. This is the latest chapter in what has been a year full of achievements, including formalizing partnerships with leading governance service providers and investors that leverage CGLytics’ vast compensation analysis and tools for their global client base and engagement work.
Founder and CEO Aniel Mahabier, upon announcing the corporate rebrand, said:
“This rebrand signifies a milestone within our organization and is a testament to the work we have done and our vision toward the future. By changing the company’s name and logo, we are better representing the unmatched solutions we bring to corporations, their board members and investors across the globe.”
CGLytics is focused exclusively on providing consistent, comprehensive, real-time data, smart analytics, ratings and a suite of screening tools, including a powerful pay-for-performance review tool. The platform is powered by structured and comprehensive performance metrics, board information and executive compensation data. The company deploys machine learning and artificial intelligence to create powerful governance workflow efficiencies.
Interested parties can learn more about CGLytics on the company website: https://cglytics.com/
CGLytics is the brand under which AMA Partners B.V. (Chamber of Commerce: 54985242) operates and provides services. CGLytics provides data analytics and intelligence on the “G” of Environmental, Social & Governance (ESG). Our solutions are designed to help corporations, institutional investors, financial institutions and professional services firms to efficiently and effectively manage the increasing challenges they face in reviewing and addressing corporate governance risks and associated decision-making. CGLytics provides an integrated cloud-based, data technology solution, to independently analyze data on the value creation and governance practices of leading listed companies across the globe, in a single convenient solution. CGLytics is a signatory to the UNPRI. Follow CGLytics on Twitter and LinkedIn .
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
IL-GILEAD-SCIENCES21.10.2018 00:32 | pressemeddelelse
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting
CA-TRUE-RELIGION19.10.2018 19:39 | pressemeddelelse
Manchester United and True Religion Launch Denim Range
ARCH-INSURANCE19.10.2018 15:12 | pressemeddelelse
Arch Insurance Announces Strategic Leadership Changes
MA-TAKEDA-PHARMACEUTICAL19.10.2018 14:02 | pressemeddelelse
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
VERTEX-PHARMACEUTICALS19.10.2018 13:56 | pressemeddelelse
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene
TX-SCHLUMBERGER-LIMITED19.10.2018 13:02 | pressemeddelelse
Schlumberger Announces Third-Quarter 2018 Results
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum